Page last updated: 2024-10-31

mexiletine and Batten Turner Congenital Myopathy

mexiletine has been researched along with Batten Turner Congenital Myopathy in 19 studies

Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.

Research Excerpts

ExcerptRelevanceReference
"we report on the first case of a woman affected by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and recessive myotonia congenita (MC), treated with mexiletine."7.96Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option. ( Biasini, F; Bramanti, P; Calabrò, RS; Naro, A; Portaro, S, 2020)
"Mexiletine treatment started at 200 mg/day and was up-titrated by 200 mg increment each three days to reach a maximum dose of 600 mg/day for total treatment duration of 18 days for each cross-over period."7.01Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study. ( Behin, A; Bouhour, F; Fontaine, B; Fournier, E; Franques, J; Hézode, M; Lacomblez, L; Magot, A; Nadaj-Pakleza, A; Payan, C; Péréon, Y; Sacconi, S; Vicart, S; Zahr, N, 2021)
"we report on the first case of a woman affected by chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and recessive myotonia congenita (MC), treated with mexiletine."3.96Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option. ( Biasini, F; Bramanti, P; Calabrò, RS; Naro, A; Portaro, S, 2020)
"Mexiletine treatment started at 200 mg/day and was up-titrated by 200 mg increment each three days to reach a maximum dose of 600 mg/day for total treatment duration of 18 days for each cross-over period."3.01Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study. ( Behin, A; Bouhour, F; Fontaine, B; Fournier, E; Franques, J; Hézode, M; Lacomblez, L; Magot, A; Nadaj-Pakleza, A; Payan, C; Péréon, Y; Sacconi, S; Vicart, S; Zahr, N, 2021)
"We evaluated 21 patients with recessive myotonia congenita referred to our institute from 1990 to 2013 and treated with mexiletine chlorhydrate."1.42Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita. ( D'Amico, A; Desaphy, JF; Lo Monaco, M; Luigetti, M; Modoni, A, 2015)
"A 27-year-old woman presented with paramyotonia congenita since her childhood."1.40Focal and abnormally persistent paralysis associated with congenital paramyotonia. ( David, A; Magot, A; Péréon, Y; Sternberg, D, 2014)
"Recessive myotonia congenita (Becker's disease)."1.33Myotonia congenita--a cause of muscle weakness and stiffness. ( Bouchard, JP; Chrestian, N; Dupré, N; Puymirat, J, 2006)
"He had myotonia congenita."1.30Unusual causes of stiffness in two hockey players. ( Burnham, R, 1997)
"Treatment with mexiletine led to resolution of the abnormalities exhibited during a short exercise test and repetitive stimulation following ice bath immersion."1.29Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy. ( Barohn, RJ; Jackson, CE; Ptacek, LJ, 1994)
"A sporadic event of myotonia congenita in a infant admitted to the Paediatric Clinic for frequent crises of apnoea, cyanosis, vomiting and difficult feeding is reported."1.28Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. ( Calevro, L; Ceccarelli, M; Rossi, B; Siciliano, G; Tarantino, E, 1992)
"A case of generalized myotonia with autosomal recessive transmission related to Becker's type is reported."1.27[Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine]. ( Pouget, J; Serratrice, G, 1983)

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19904 (21.05)18.7374
1990's4 (21.05)18.2507
2000's2 (10.53)29.6817
2010's6 (31.58)24.3611
2020's3 (15.79)2.80

Authors

AuthorsStudies
Vicart, S2
Franques, J1
Bouhour, F1
Magot, A2
Péréon, Y2
Sacconi, S1
Nadaj-Pakleza, A1
Behin, A1
Zahr, N1
Hézode, M1
Fournier, E1
Payan, C1
Lacomblez, L1
Fontaine, B2
Stunnenberg, BC1
LoRusso, S1
Arnold, WD1
Barohn, RJ2
Cannon, SC1
Griggs, RC1
Hanna, MG1
Matthews, E1
Meola, G1
Sansone, VA1
Trivedi, JR1
van Engelen, BGM1
Statland, JM1
Portaro, S2
Biasini, F1
Bramanti, P2
Naro, A2
Calabrò, RS2
Bramanti, A1
Leo, A1
Manuli, A1
Balletta, T1
Trinchera, A1
Desaphy, JF3
Carbonara, R2
Costanza, T1
Conte Camerino, D2
David, A1
Sternberg, D1
Lo Monaco, M2
D'Amico, A2
Luigetti, M1
Modoni, A2
Roussel, J1
Imbrici, P1
Pagliarani, S1
Lucchiari, S2
Ginanneschi, F1
Mignarri, A1
Ulzi, G1
Comi, GP1
Rossi, A1
Dotti, MT1
Brooke, MH1
Chrestian, N1
Puymirat, J1
Bouchard, JP1
Dupré, N1
Pouget, J1
Serratrice, G1
Jackson, CE1
Ptacek, LJ1
Burnham, R1
Kwieciński, H1
Ryniewicz, B1
Ostrzycki, A1
Ceccarelli, M1
Rossi, B2
Siciliano, G2
Calevro, L1
Tarantino, E1
Leheup, B1
Himon, F1
Morali, A1
Brichet, F1
Vidailhet, M1
Nezu, A1
Yamashita, S1
Miyake, S1
Hayashi, M1
Iwamoto, H1
Sartucci, F1

Reviews

1 review available for mexiletine and Batten Turner Congenital Myopathy

ArticleYear
Guidelines on clinical presentation and management of nondystrophic myotonias.
    Muscle & nerve, 2020, Volume: 62, Issue:4

    Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Ele

2020

Trials

2 trials available for mexiletine and Batten Turner Congenital Myopathy

ArticleYear
Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Neuromuscular disorders : NMD, 2021, Volume: 31, Issue:11

    Topics: Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mexiletine; Middle Aged;

2021
Treatment of myotonia with antiarrhythmic drugs.
    Acta neurologica Scandinavica, 1992, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Drug Admi

1992

Other Studies

16 other studies available for mexiletine and Batten Turner Congenital Myopathy

ArticleYear
Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option.
    Medicine, 2020, Jul-10, Volume: 99, Issue:28

    Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Humans; Mexiletine; Myotonia Congenita; Polyradic

2020
Beyond the muscular involvement in non-dystrophic myotonias: The emerging role of neuromodulation.
    Restorative neurology and neuroscience, 2018, Volume: 36, Issue:4

    Topics: Adult; Analysis of Variance; Anti-Arrhythmia Agents; Electromyography; Evoked Potentials, Motor; Fem

2018
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
    Experimental neurology, 2014, Volume: 255

    Topics: Animals; Carbamazepine; Disease Models, Animal; Flecainide; HEK293 Cells; Humans; Mexiletine; Muscle

2014
Focal and abnormally persistent paralysis associated with congenital paramyotonia.
    BMJ case reports, 2014, Jun-17, Volume: 2014

    Topics: Female; Humans; Mexiletine; Mutation; Myotonia Congenita; NAV1.4 Voltage-Gated Sodium Channel; Paral

2014
Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2015, Volume: 126, Issue:2

    Topics: Action Potentials; Adolescent; Adult; Aged; Child; Evoked Potentials, Motor; Female; Humans; Male; M

2015
Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.
    Neurology, 2016, May-31, Volume: 86, Issue:22

    Topics: Cell Line; Child; Diagnosis, Differential; Female; Flecainide; Humans; Mexiletine; Mutation; Myotoni

2016
Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita.
    Neurophysiologie clinique = Clinical neurophysiology, 2017, Volume: 47, Issue:3

    Topics: Action Potentials; Adult; Electromyography; Female; Humans; Male; Mexiletine; Muscle Contraction; Mu

2017
Fiction: the Christmas card.
    Neurology, 2005, Mar-08, Volume: 64, Issue:5

    Topics: Activities of Daily Living; Adult; Aging; Anecdotes as Topic; Anti-Arrhythmia Agents; Humans; Male;

2005
Myotonia congenita--a cause of muscle weakness and stiffness.
    Nature clinical practice. Neurology, 2006, Volume: 2, Issue:7

    Topics: Diagnosis, Differential; Electromyography; Female; Genes, Recessive; Humans; Mexiletine; Middle Aged

2006
[Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
    Revue neurologique, 1983, Volume: 139, Issue:11

    Topics: Adult; Exercise Therapy; Female; Humans; Mexiletine; Muscle Hypotonia; Myotonia Congenita; Propylami

1983
Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy.
    Muscle & nerve, 1994, Volume: 17, Issue:7

    Topics: Cold Temperature; Electric Stimulation; Electromyography; Exercise Test; Female; Humans; Mexiletine;

1994
Unusual causes of stiffness in two hockey players.
    Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 1997, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Hockey; Humans; Male; Mexiletine; Myotonia; Myotonia Congenita

1997
Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine.
    Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:5

    Topics: Electromyography; Humans; Infant, Newborn; Male; Mexiletine; Myotonia Congenita

1992
[Value of mexiletine in the treatment of Thomsen-Becker myotonia].
    Archives francaises de pediatrie, 1986, Volume: 43, Issue:1

    Topics: Drug Resistance; Humans; Infant, Newborn; Male; Mexiletine; Myotonia Congenita; Propylamines; Time F

1986
[Effective treatment of paramyotonia congenita by mexiletene].
    No to hattatsu = Brain and development, 1986, Volume: 18, Issue:3

    Topics: Adolescent; Humans; Male; Mexiletine; Myotonia Congenita; Propylamines

1986
[Therapy of myotonia congenita].
    Minerva pediatrica, 1986, Aug-31, Volume: 38, Issue:15-16

    Topics: Adult; Female; Humans; Male; Mexiletine; Myotonia Congenita

1986